WHO WE ARE…
The NanoB2A group is a multidisciplinary research team led by Prof. Laura M. Lechuga. We are physicists, engineers, chemists, and biologists working in the broad field of Nanobiotechnology. Our motivation is to develop new and cutting-edge biosensor nanotechnologies using photonics, one of the key technologies of the 21st century, to promote and boost healthcare and well-being for our society.
WHAT WE DO…
Our research focuses on the development of photonic point-of-care biosensors and their employment in clinical, biomedical, and environmental areas. We mainly exploit Nanoplasmonics and Silicon Nanophotonics technologies to accomplish integrated biosensing systems for the label-free, real-time, and multiplexed analysis at the point of care. Our activity encompasses the entire process of generating new biosensor devices, including fundamental research and theoretical design, nanofabrication, surface biofunctionalization, lab-on-a-chip integration, and their final validation in real scenarios.
WHERE WE ARE…
NanoB2A group is established at the Catalan Institute of Nanoscience and Nanotechnology (ICN2), in Barcelona (Spain), belonging to the CERCA network of Catalan Research Institutes and integrated in BIST (Barcelona Institute of Science and Technology). The NanoB2A belongs as well to the Spanish National Research Council (CSIC) and the Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN).
